Authored by - Chapal Mehra, public health specialist, New Delhi and Zarir Udwadia, consultant physician, Hinduja and Breach ...

WASHINGTON (AP) — Scientists are hot on the trail of a new tuberculosis treatment that a small study suggests might one day offer an alternative to battle this deadly lung disease, even if it’s ...

Biophysicists have discovered why the bacteria that cause tuberculosis (TB) are naturally somewhat resistant to antibiotics known as fluoroquinolones. Their findings, based on mapping the detailed ...

Tufts University researchers’ approach uncovers how TB treatments can best work together at the cellular level to speed better cures Tuberculosis (TB) is the world’s deadliest infectious disease—and ...

Tuberculosis (TB) remains a global health challenge, affecting millions each year. In 2023, an estimated 10.8 million people contracted TB, with 1.25 million deaths, according to the World Health ...

Weill Cornell Medicine researchers and the TB Drug Accelerator have received two grants totaling $6.8 million from the Bill & Melinda Gates Foundation to study tuberculosis (TB) drug development. This ...

Mumbai: Over 1,000 patients with drug-resistant tuberculosis in Mumbai started a new drug combination that reduced the ...

The approval significantly strengthens Delhi’s ability to diagnose multidrug-resistant (MDR-TB) and drug-resistant ...

For 2007, the WHO estimated 511,000 cases of multidrug-resistant (MDR)-TB, representing approximately 5% of all TB cases worldwide. Extensively drug-resistant (XDR-TB) strains have been detected in at ...

WASHINGTON -- Tuberculosis is the No. 1 killer of women of childbearing age worldwide, and the epidemic is growing with the spread of bacteria that is resistant to drugs that have worked in the past.

TB is an infectious disease that is far from being eradicated and controlled. The treatment for TB is associated with noncompliance to therapy because it consists of a long-term treatment with a ...